glp-1 obesity drugs Considering for weight loss? Advice from a doctor who's used them : NPR How are GLP-1 drugs impacting

GLP-1 is rapidly degraded by an enzyme named dipeptidyl peptidase-IV (DPP-4), converting to bioinactive products GLP-1 (9-36) and GLP-1 (9-37) ( GLP-1 exerts its function by binding to GLP-1R and is involved in the development and progression of many diseases ( GLP-1R agonists (GLP-1RAs) are a group of GLP-1 analogues that are resistant to DPP4-mediated degradation, working through activating GLP-1R and its downstream signaling ( The expression of GLP-1R remains controversial due to the lack of specific antibody against GLP-1R, with most of the literatures using qPCR to detect mRNA levels ( 2 GLP-1 in regulating immune system 2.1 The role of GLP-1 in innate immune cells Recent studies have demonstrated that GLP-1 and its analogues exert regulatory functions in innate immune cells, especially macrophages

Most commercial plans cover GLP-1 medications for type 2 diabetes (Ozempic, Mounjaro) but many exclude or restrict coverage for weight loss (Wegovy, Zepbound)

Weve already seen similar patterns with other GLP-1 medications, including oral semaglutide

NAFLD is tightly associated with the global pandemic of obesity, metabolic syndrome (MS) and T2D, as well as with several genetic factors

We still dont have a clear understanding